ADAGE CAPITAL PARTNERS GP, L.L.C. - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 57 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$5,511,000
-56.9%
755,969
-40.7%
0.01%
-56.0%
Q2 2021$12,775,000
+4.9%
1,274,9130.0%0.02%0.0%
Q1 2021$12,175,000
-23.5%
1,274,913
-12.1%
0.02%
-28.6%
Q4 2020$15,909,000
+32.8%
1,450,268
+7.4%
0.04%
+16.7%
Q3 2020$11,977,0001,350,2680.03%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 2,945,948$5,184,8681.60%
Aisling Capital Management LP 1,043,267$1,836,1500.90%
Knott David M Jr 140,921$2480.10%
XTX Topco Ltd 233,493$410,9480.07%
Pentwater Capital Management LP 5,975,000$10,516,0000.07%
Atom Investors LP 49,413$86,9670.03%
EcoR1 Capital, LLC 676,296$1,190,2810.03%
Forefront Analytics, LLC 26,619$46,8500.03%
FNY Investment Advisers, LLC 11,500$200.02%
CORNERCAP INVESTMENT COUNSEL INC 80,979$142,5230.02%
View complete list of POSEIDA THERAPEUTICS INC shareholders